As the case of plagiarism of the two products illustrated in the new Medigard website has not been settled, it would appear that the new directors are no more ethical than the previous ones. This is now being reflected in the present share prices - near record lows. Hard to see new, big capital raising being a success with this issue unresolved.
MGZ Price at posting:
2.0¢ Sentiment: None Disclosure: Held
